Research
Search
Genes / Clones
Expression
Mutants / Tg
Antibodies
Anatomy / GO / Human Disease / Chemical
Publications
Data Mining
Downloads
Data Model
AllianceMine
BioMart
Genomics
BLAST
ZFIN
Ensembl
NCBI
UCSC
Genome Browsers
ZFIN
Ensembl
Vega
GRC
UCSC
NCBI
Resources
Zebrafish Genomics
Other Genome Databases
Resources
General
The Zebrafish Book
Protocol Wiki
Antibody Wiki
Anatomy Atlases
Resources for Students and Educators
Zebrafish Programs
ZF-Health
Husbandry Resources
More...
Resource Centers
Zebrafish International Resource Center (ZIRC)
China Zebrafish Resource Center (CZRC)
European Zebrafish Resource Center (EZRC)
Community
Announcements
News
Meetings
Jobs
Alliance Community Forum
Search
People
Labs
Companies
Societies
International Zebrafish Society (IZFS)
Zebrafish Disease Models Society (ZDMS)
Genetics Society of America (GSA)
Zebrafish Husbandry Association
Support
Nomenclature
Nomenclature Conventions
Line Designations
Wild-Type Lines
Submit a Proposed Gene Name
Submit a Proposed Mutant/Tg Line Name
Publications
Guidelines for Authors
Zebrashare
Citing ZFIN
Using ZFIN
Help & Tips
Glossary
Single Box Search Help
Submit Data
Terms of Use
About Us
About ZFIN
Contact Information
Statistics
Committees
Jobs at ZFIN
Sign In
Phenotype Figure Summary
Marker:
boc
Conditions:
Standard or Control
Publication
Data
Fish
Anatomy
Lencer
et al.
, 2023
Fig. 3
boc
co24/co24
; st1002Tg
neural tube Wnt signaling pathway decreased occurrence, abnormal
slow muscle cell Wnt signaling pathway decreased occurrence, abnormal
Kearns
et al.
, 2021
Fig. 1
boc
ty54z/+
; boc
co24/+
; vu12Tg/vu12Tg
, 
boc
co24/co24
; vu12Tg/vu12Tg
oligodendrocyte decreased amount, abnormal
oligodendrocyte EGFP expression decreased amount, abnormal
whole organism curved, abnormal
Fig. 2
boc
co24/co24
; vu12Tg/vu12Tg
motor neuron ab2-isl labeling decreased amount, abnormal
motor neuron decreased amount, abnormal
oligodendrocyte
mbpa
expression decreased amount, abnormal
oligodendrocyte
myrf
expression decreased amount, abnormal
oligodendrocyte ab1-sox10 labeling decreased amount, abnormal
oligodendrocyte decreased amount, abnormal
oligodendrocyte EGFP expression decreased amount, abnormal
Fig. 3
boc
co24/co24
spinal cord dorsal region
olig2
expression decreased amount, abnormal
spinal cord ventral region
nkx2.2a
expression decreased amount, abnormal
Fig. 4
boc
co24/co24
; vu12Tg/vu12Tg
oligodendrocyte EGFP expression decreased amount, abnormal
spinal cord ab5-sox2 labeling decreased amount, abnormal
spinal cord oligodendrocyte cell fate commitment decreased process quality, abnormal
Fig. 5
boc
co24/co24
; st1001Tg/st1001Tg; vu12Tg/vu12Tg
oligodendrocyte EGFP expression decreased amount, abnormal
oligodendrocyte mCherry expression decreased amount, abnormal
Fig. 6
boc
co24/co24
spinal cord
olig2
expression decreased amount, abnormal
spinal cord adaxial-abaxial axis
boc
expression spatial pattern, abnormal
spinal cord adaxial-abaxial axis
ptch2
expression spatial pattern, abnormal
spinal cord ventral region
boc
expression decreased amount, abnormal
Fig. 7
boc
co24/co24
regulation of smoothened signaling pathway decreased process quality, abnormal
spinal cord oligodendrocyte cell fate commitment decreased process quality, abnormal
spinal cord ventral region
olig2
expression decreased amount, abnormal
spinal cord ventral region
ptch2
expression decreased amount, abnormal
Bergeron
et al.
, 2011
Fig. 1
boc
ty54z/ty54z
axon extension involved in axon guidance process quality, abnormal
cranial nerve II decreased length, abnormal
cranial nerve II misrouted, abnormal
diencephalon glial cell mislocalised, abnormal
forebrain physical object quality, abnormal
forebrain regionalization process quality, abnormal
postoptic commissure absent, abnormal
retinal ganglion cell axon guidance process quality, abnormal
Fig. 2
boc
ty54z/ty54z
regulation of smoothened signaling pathway process quality, abnormal
Fig. 4
boc
ty54z/ty54z
, 
WT + MO1-boc
axon extension involved in axon guidance process quality, abnormal
cranial nerve II misrouted, abnormal
midbrain ventral region physical object quality, abnormal
post-vent region curved ventral, abnormal
retinal ganglion cell axon guidance process quality, abnormal
trunk curved ventral, abnormal
Fig. 5
boc
ty54z/ty54z
, 
boc
ty54z/ty54z
; vu17Tg
regulation of smoothened signaling pathway process quality, abnormal
Fig. 6
vu17Tg + MO1-boc
forebrain development process quality, abnormal
forebrain physical object quality, abnormal
lateral floor plate physical object quality, abnormal
regulation of smoothened signaling pathway process quality, abnormal
spinal cord dorsal/ventral patterning process quality, abnormal
Fig. S2
boc
ty54z/ty54z
adenohypophysis development process quality, abnormal
adenohypophysis physical object quality, abnormal
embryonic viscerocranium morphogenesis process quality, abnormal
neurocranial trabecula malformed, abnormal
skeletal muscle fiber development process quality, abnormal
slow muscle cell decreased amount, abnormal
ventral mandibular arch increased width, abnormal
ventral mandibular arch malformed, abnormal
Phenotype Annotation (1994-2006)
Fig. for (ty54z)
boc
ty54z/ty54z
retinal ganglion cell axon guidance quality, abnormal
whole organism lethal (sensu genetics), abnormal
Connor
et al.
, 2005
Fig. 5
WT + MO1-boc
, 
WT + MO2-boc
axon guidance disrupted, abnormal
caudal commissure axon mislocalised, abnormal
caudal commissure defasciculated, abnormal
dorsal/ventral axon guidance disrupted, abnormal
dorsoventral diencephalic tract morphology, abnormal
forebrain development disrupted, abnormal
Karlstrom
et al.
, 1996
Fig. 4
boc
ty54z/ty54z
postoptic commissure aplastic, abnormal
retinal ganglion cell axon guidance process quality, abnormal
retinal ganglion cell axon misrouted, abnormal
tract of the postoptic commissure axon mislocalised laterally, abnormal
Your Input Welcome
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Name:
Institution:
Email address:
Please leave blank:
Subject:
Comments:
Send your comments
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.